Question to the Department of Health and Social Care:

To ask His Majesty's Government what action has been taken by the NHS Cancer Vaccine Launch Pad to ensure that work on personalised vaccines in cancer treatment will benefit patients with brain cancer.

The NHS Cancer Vaccine Launch Pad (CVLP) is a platform that aims to accelerate the development of cancer vaccines and speed up cancer patient access to mRNA personalised cancer vaccine clinical trials. The CVLP has played a key role in accelerating trial activity in cancer research, with CVLP sites driving faster site activation and enrolment timelines. The platform is company- and clinical trial- agnostic. The CVLP would encourage any company that wishes to deliver trials via the platform, including those developing personalised cancer vaccines for brain tumours, to get in contact to explore how the platform can support their research.